Barcelona - October 3, 2024 - Adrián Trejo de la Rosa, CEO and co-founder of Xtraordinary People, leads an innovative project aiming to revolutionize neurodiversity care. After achieving success in Spain, Trejo is now poised to bring this model to the United States with the goal of transforming how neurodivergence is approached.
Trejo explains that the inspiration for this project came from observing that “neurodivergent individuals were not receiving the comprehensive support they need”. He points out that the development of these individuals is deeply connected to their family, educational, and social environments, yet he laments that “these aspects are rarely integrated into conventional treatments”. To fill this gap, Xtraordinary People has developed a bio-psycho-social approach that encompasses all these areas, enabling neurodivergent individuals to fully realize their potential.
Unlike traditional approaches, Trejo highlights that his organization distinguishes itself with its holistic methodology. This method not only addresses medical aspects but also actively involves the family, school, and community. The multidisciplinary team at Xtraordinary People works on creating individualized treatments that offer rapid diagnoses and immediate access to therapies. “We don’t treat neurodiversity as a deficit - Trejo asserts-, but as a natural expression of human diversity that should be understood and valued”.
Expansion to the United States: a key step
According to Trejo, the expansion to the United States represents a crucial opportunity for the organization. “We aim to open 10 centers in the U.S. by 2025”, he says, emphasizing that partnerships with universities and research centers will be essential for developing new therapies. His vision is to overcome “the barriers faced by neurodivergent individuals, especially in coordinating between family, educational, and medical environments”. With this, Trejo hopes to establish Xtraordinary People as a leader not only in clinical treatment but also in social inclusion.
Innovation at Xtraordinary People is grounded in collaboration with prestigious international institutions such as the Spanish neuroscience company Synaptia Health Projects, Mexico's National Institute of Neurology and Neurosurgery ‘Manuel Velasco Suárez’ (INNN), Spain’s Rey Juan Carlos University, and the Spanish National Research Council (CSIC). These alliances help develop advanced biotechnological solutions for neurodiversity care.
The approach centers on research and the use of emerging technologies such as artificial intelligence and data analysis to provide more precise diagnoses and personalized treatments. Thanks to this continuous collaboration, Xtraordinary People remains at the forefront of neuroscience, ensuring constant improvement in its methods and contributing to global advancements in neurodiversity care.
Commitment to Inclusive environments
Social inclusion is another fundamental pillar of Xtraordinary People’s approach. Trejo stresses that his organization “goes beyond medical care” with the aim of creating environments where neurodivergent individuals are understood and included in their families, communities, and workplaces. To achieve this, Xtraordinary People offers training for educators, support for families, and tools that facilitate the employment of neurodivergent individuals.
Finally, Trejo shares a hopeful message for families living with neurodiversity: “Neurodiversity is not a limitation, but a natural variation of the human experience”. He emphasizes that families are not alone in this journey and that “eliminating stigma and creating inclusive environments” is essential for neurodivergent individuals to reach their full potential. Trejo assures that “Xtraordinary People is committed to leading this change by providing the necessary support and promoting a culture of inclusion”.
Media Contact
Company Name: SYNAPTIA HEALTH GROUP SL
Contact Person: Press Office
Email: Send Email
Country: United States
Website: https://www.xtraordinarypeople.io/
